Table 1.
Moxidectin plasma and breast milk PK results
Parametera | Value (mean ± SD)b |
---|---|
Cmax (ng/ml) | 87 ± 25 |
tmax (h) | 4.18 ± 1.59 |
AUC (ng·h/ml) | 4,046 ± 1,796 |
λz (h−1) | 0.00093 ± 0.00029 |
t1/2 (h) | 832 ± 321 |
CL/F (liters/h) | 2.349 ± 1.067 |
Vλz/F (liters) | 2,526 ± 772 |
% dose excreted in milk | 0.701 ± 0.299 |
Amt excreted in milk (mg) | 0.056 ± 0.024 |
CLmilk (liters/h) | 0.016 ± 0.009 |
AUCmilk/AUC | 1.77 ± 0.66 |
Absolute infant dose (mg) | 0.056 ± 0.024 |
Relative infant dose (%) | 8.73 ± 3.17 |
AUC, total area under the concentration-time curve; AUCmilk, AUC for moxidectin in breast milk; Cmax, peak plasma concentration; CL/F, apparent oral dose clearance; CLmilk, clearance in milk; t½, terminal phase elimination half-life;, tmax, time to Cmax; Vz/F, apparent volume of distribution; λz, terminal-phase elimination rate constant.
n = 12.